Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(8 sites)
United States
Clinical Trial Site, La Jolla, California Clinical Trial Site, Indianapolis, Indiana Canada
Clinical Trial Site, Montreal Clinical Trial Site, Toronto Netherlands
Clinical Trial Site, Amsterdam Clinical Trial Site, Groningen United Kingdom
Clinical Trial Site, Huntley Street Clinical Trial Site, Sheffield